AdaptHealth (AHCO) Stock Forecast, Price & News

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AdaptHealth in the last twelve months. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AHCO shares.
View AHCO analyst ratings or view top-rated stocks.

7 Wall Street research analysts have issued twelve-month price targets for AdaptHealth's shares. Their AHCO share price forecasts range from $11.00 to $30.00. On average, they anticipate the company's share price to reach $18.92 in the next year. This suggests a possible upside of 82.5% from the stock's current price.
View analysts price targets for AHCO or view top-rated stocks among Wall Street analysts.

AdaptHealth's stock was trading at $19.22 on January 1st, 2023. Since then, AHCO stock has decreased by 46.0% and is now trading at $10.37.
View the best growth stocks for 2023 here.

AdaptHealth saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 11,640,000 shares, a decrease of 8.9% from the April 30th total of 12,780,000 shares. Based on an average trading volume of 1,510,000 shares, the days-to-cover ratio is presently 7.7 days. Approximately 15.8% of the shares of the stock are sold short.
View AdaptHealth's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our AHCO earnings forecast.

AdaptHealth Corp. (NASDAQ:AHCO) posted its quarterly earnings data on Thursday, November, 4th. The company reported $0.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.28 by $0.08. The company earned $653.30 million during the quarter, compared to analyst estimates of $638.74 million. AdaptHealth had a net margin of 1.44% and a trailing twelve-month return on equity of 3.17%. The company's quarterly revenue was up 129.7% on a year-over-year basis. During the same period in the previous year, the business posted $0.05 EPS.

ETFs with the largest weight of AdaptHealth (NASDAQ:AHCO) stock in their portfolio include Janus Henderson Small Cap Growth Alpha ETF (JSML), SPDR S&P Health Care Services ETF (XHS), Invesco S&P SmallCap Health Care ETF (PSCH), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD), Invesco S&P SmallCap 600 Pure Growth ETF (RZG), Fidelity Small-Mid Cap Opportunities ETF (FSMO), Invesco S&P SmallCap Value with Momentum ETF (XSVM) and First Trust Small Cap Growth AlphaDEX Fund (FYC).

Based on aggregate information from My MarketBeat watchlists, some companies that other AdaptHealth investors own include Advanced Micro Devices (AMD), Johnson & Johnson (JNJ), Advance Auto Parts (AAP), American International Group (AIG), Biogen (BIIB), BioMarin Pharmaceutical (BMRN), Bristol-Myers Squibb (BMY), Caterpillar (CAT), Cisco Systems (CSCO) and CVS Health (CVS).

AdaptHealth trades on the NASDAQ under the ticker symbol "AHCO."

AdaptHealth's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (8.81%), FMR LLC (7.27%), Truist Financial Corp (2.90%), Rubric Capital Management LP (2.46%), Sumitomo Mitsui Trust Holdings Inc. (2.44%) and State Street Corp (1.97%). Insiders that own company stock include Aero Holdings Ii Ll Skyknight, Alan G Quasha, Assured Investment Management, Christopher J Joyce, Dale B Wolf, Daniel Bunting, Everest Hill Group Inc, Frank Mullen, Jason A Clemens, Ronald T Mcdaniel, Shaw Rietkerk, Skyknight Capital Fund Ii, LP and Stephen P Griggs.
View institutional ownership trends.

Shares of AHCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AHCO stock can currently be purchased for approximately $10.37.

AdaptHealth (NASDAQ:AHCO) has a market capitalization of $1.39 billion and generates $3.00 billion in revenue each year. The company earns $69.32 million in net income (profit) each year or $0.12 on an earnings per share basis.

The company employs 10,900 workers across the globe.

AdaptHealth's mailing address is 220 West Germantown Pike Suite 250, Plymouth Meeting PA, 19462. The official website for the company is www.adapthealth.com. The company can be reached via phone at (610) 424-4515 or via email at dsullivan@equityny.com.